Skip to main content

noComment
Sanofi ups its bid to buy Genzyme

corporate

| |

French pharmaceuticals group Sanofi-Aventis has made a new bid to buy US biotech company Genzyme. Sanofi is offering 71 dollars a share, or just over 55 euros. That is two dollars a share more than an offer Sanofi made last month. It hopes the new valuation will be enough to get Genzyme to open its books as part of “partial due diligence.”

More about: , ,

Copyright © 2012 euronews

| |

Log in
Please enter your login details